Adductor Canal Block With or Without Biceps Femoris Short Head Block in Total Knee Arthroplasty

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorCukurova University

About this trial

Total knee arthroplasty is associated with moderate to severe postoperative pain, which may delay mobilization and recovery. Multimodal analgesia including regional anesthesia techniques is widely used to improve outcomes. The adductor canal block (ACB) provides anteromedial knee analgesia but may not adequately cover the posterolateral region.

The biceps femoris short head (BiFeS) block is a novel motor-sparing regional anesthesia technique targeting the posterolateral capsule of the knee. This randomized controlled trial aims to compare the analgesic efficacy and functional outcomes of ACB combined with BiFeS block versus ACB alone in patients undergoing total knee arthroplasty.

The primary outcome is posterior knee pain at postoperative 6 hours. Secondary outcomes include pain scores within 48 hours, opioid consumption, early and late functional recovery, and opioid-related adverse effects.

Eligibility criteria

Qualifiers

ASA I-III

Adult patients undergoing unilateral primary TKA

Planned spinal anesthesia

Written informed consent

Disqualifiers

Coagulopathy

Drug allergy

BMI > 35

Renal/hepatic failure

Trial design

Treatments tested in this trial

  • Adductor Canal Block
  • Biceps Femoris Short Head Block
  • Sham Biceps Femoris Short Head Block

Treatment groups

132 Participants
are divided into 2 treatment groups

Sponsors and collaborators